Tang Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Tang Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21,000	Closed	-$2.25M	–	120
2023 Q1	$2.25M	Buy	+21,000	New	+$2.42M	0.34%	66

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Tang Capital Management's RXDX Position: Q2 2023 in Review

Tang Capital Management sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 21,000 shares — an estimated $2.25M sold.

Tang Capital Management first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $2.25M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Tang Capital Management reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Tang Capital Management sold 21,000 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $2.25M.
Tang Capital Management first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Tang Capital Management's Prometheus Biosciences, Inc. Common Stock position peaked at $2.25M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Tang Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.